Granza Bio Analysis: $7M Raised
What is Granza Bio?
Granza Bio develops precision shell technology to deliver immune-inspired therapeutic agents, targeting diseases such as cancer and infections.
Founded
2024
Revenue
$5M
Company Stage
Seed
Investors
- Felicis Ventures
- Y Combinator
- Refactor Capital
YC Batch
W24
Product Features & Capabilities
- Precision shell technology, targeted therapeutic delivery, cancer treatment, autoimmune disease treatment, delivery of genetic modifiers, packaging of attack particles, RNAs, and proteins, overcoming immunological activation, targeting hard-to-reach organs.
How much Granza Bio raised
Seed - $7M
July 3, 2024Lead Investor: Felicis and Y Combinator
Who are the founders of Granza Bio
AN
Ashwin Nandakumar
Founder
AJ
Ashwin Jainarayanan
Founder
